https://www.zonebourse.com/cours/action/TRAWS-PHARMA-INC-46372025/actualite/Onconova-Therapeutics-administre-le-dosage-a-la-premiere-patiente-de-l-essai-de-phase-1-2a-du-nara-43829212/?utm_source=telegram&utm_medium=social&utm_campaign=share